Poly Medicure Limited — Board Meeting, 05-02-2026: Outcome of Board Meeting
05-02-2026 | 03:03 pm
05-02-2026 | 03:03 pm
Poly Medicure's board approved Q3 consolidated results: Revenue at **448.41 Cr**, PAT at **78.38 Cr**. Strategic highlights include the acquisition of Medistream SA (~**248 Cr**) during the quarter and a grant of 2,000 employee stock options.
No comments yet. Be the first to comment!
